Schering-Plough Brain Cancer Drug Wins Expanded OK (Reuters
Reuters - Schering-Plough Corp.,. on Wednesday
said U.S. regulators had approved earlier use of its brain
cancer drug Temodar following a trial that last year showed it
prolonged lives of patients.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace